Novavax Files for Provisional Approval of its COVID-19 Vaccine in Australia

Go back to Novavax Files for Provisional Approval of its COVID-19 Vaccine in Australia
Novavax, Inc. (NASDAQ: NVAX) Delayed: 9.85 -0.34 (3.34%)
Previous Close $10.19    52 Week High $9.23 
Open $10.02    52 Week Low $1.16 
Day High $10.24    P/E N/A 
Day Low $9.73    EPS $-0.30 
Volume 2,219,174